Photochemical Internalization of Tumor-Targeted Protein Toxins

被引:52
作者
Weyergang, Anette [1 ]
Selbo, Pal K. [1 ,2 ]
Berstad, Maria E. B. [1 ]
Bostad, Monica [1 ]
Berg, Kristian [1 ]
机构
[1] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Radiat Biol, Inst Canc Res, N-0310 Oslo, Norway
[2] PCI Biotech AS, N-1366 Lysaker, Norway
关键词
photodynamic; PDT; PCI; targeting; saporin; gelonin; RIBOSOME-INACTIVATING PROTEINS; MONOCLONAL-ANTIBODIES; MECHANISMS;
D O I
10.1002/lsm.21084
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Photochemical internalization (PCI) is a method for intracellular delivery of hydrophilic macromolecular drugs with intracellular targets as well as other drugs with limited ability to penetrate cellular membranes. Such drugs enter cells by means of endocytosis and are to a large extent degraded by hydrolytic enzymes in the lysosomes unless they possess a mechanism for cytosolic translocation. PCI is based on photodynamic therapy (PDT) specifically targeting the endosomes and lysosomes of the cells, so that the drugs in these vesicles can escape into the cytosol from where they can reach their targets. The preferential retention of the photosensitizer (PS) in tumor tissue in combination with controlled light delivery makes PCI relatively selective for cancer tissue. The tumor specificity of PCI can be further increased by delivery of drugs that selectively target the tumors. Indeed, this has been shown by PCI delivery of several targeted protein toxins. Targeted protein toxins may be regarded as ideal drugs for PCI delivery, and may represent the clinical future for the PCI technology. Lasers Surg. Med. 43: 721-733, 2011. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:721 / 733
页数:13
相关论文
共 120 条
[31]   PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles [J].
Engesæter, BO ;
Bonsted, A ;
Berg, K ;
Hogset, A ;
Engebråten, O ;
Fodstad, O ;
Curiel, DT ;
Mælandsmo, GM .
CANCER GENE THERAPY, 2005, 12 (05) :439-448
[32]   Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors [J].
Ferrario, A ;
Fisher, AM ;
Rucker, N ;
Gomer, CJ .
CANCER RESEARCH, 2005, 65 (20) :9473-9478
[33]  
Fingar V H, 1996, J Clin Laser Med Surg, V14, P323
[34]   Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD) [J].
Fingar, VH ;
Kik, PK ;
Haydon, PS ;
Cerrito, PB ;
Tseng, M ;
Abang, E ;
Wieman, TJ .
BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) :1702-1708
[35]   Clinical experience with denileukin diftitox (ONTAK) [J].
Foss, F .
SEMINARS IN ONCOLOGY, 2006, 33 (01) :S11-S16
[36]   Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: Implications for cancer immunotherapy [J].
Friedman, LM ;
Rinon, A ;
Schechter, B ;
Lyass, L ;
Lavi, S ;
Bacus, SS ;
Sela, M ;
Yarden, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) :1915-1920
[37]   Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization [J].
Fukumura, Dai ;
Jain, Rakesh K. .
MICROVASCULAR RESEARCH, 2007, 74 (2-3) :72-84
[38]   Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize [J].
Fukumura, Dai ;
Jain, Rakesh K. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 101 (04) :937-949
[39]   Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy [J].
Hahn, Stephen M. ;
Putt, Mary E. ;
Metz, James ;
Shin, Daniel B. ;
Rickter, Elizabeth ;
Menon, Chandrakala ;
Smith, Debbie ;
Glatstein, Eli ;
Fraker, Douglas L. ;
Busch, Theresa M. .
CLINICAL CANCER RESEARCH, 2006, 12 (18) :5464-5470
[40]   Photochemical transfection: A new technology for light-induced, site-directed gene delivery [J].
Hogset, A ;
Prasmickaite, L ;
Tjelle, TE ;
Berg, K .
HUMAN GENE THERAPY, 2000, 11 (06) :869-880